Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Balance Sheet: Assets 

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Johnson & Johnson, consolidated balance sheet: assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Cash and cash equivalents 21,859 14,127 14,487 13,985 17,305
Marketable securities 1,068 9,392 17,121 11,200 1,982
Accounts receivable trade, less allowances 14,873 16,160 15,283 13,576 14,481
Inventories 11,181 12,483 10,387 9,344 9,020
Prepaid expenses and other receivables 4,514 3,132 3,701 3,132 2,392
Assets held for sale 94
Current assets 53,495 55,294 60,979 51,237 45,274
Property, plant and equipment, net 19,898 19,803 18,962 18,766 17,658
Intangible assets, net 34,175 48,325 46,392 53,402 47,643
Goodwill 36,558 45,231 35,246 36,393 33,639
Deferred taxes on income 9,279 9,123 10,223 8,534 7,819
Other assets 14,153 9,602 10,216 6,562 5,695
Non-current assets 114,063 132,084 121,039 123,657 112,454
Total assets 167,558 187,378 182,018 174,894 157,728

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Johnson & Johnson current assets decreased from 2021 to 2022 and from 2022 to 2023.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Johnson & Johnson property, plant and equipment, net increased from 2021 to 2022 and from 2022 to 2023.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Johnson & Johnson non-current assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Johnson & Johnson total assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Johnson & Johnson cash and cash equivalents decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Marketable securities Amount of investment in marketable security, classified as current. Johnson & Johnson marketable securities decreased from 2021 to 2022 and from 2022 to 2023.
Accounts receivable trade, less allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Johnson & Johnson accounts receivable trade, less allowances increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Johnson & Johnson inventories increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.